Response | N | % |
---|
Complete Response (CR) | 1 | 7 |
Stable Disease (SD) | 5 | 36 |
Progressive Disease (PD) | 7 | 50 |
Unevaluable * | 1 | 7 |
- * Patient 14012 was unevaluable because he was taken off study after receiving only one cycle of protocol therapy due to adverse events, and never had follow-up disease evaluations.